Berrut G, Bouhanick B, Fabbri P, Guilloteau G, Bled F, Le Jeune J J, Fressinaud P, Marre M
Service de Médecine B, Centre Hospitalier Universitaire, Angers, France.
Clin Nephrol. 1997 Aug;48(2):92-7.
Hypertension and non-insulin-dependent diabetes mellitus (NIDDM) are two major risk factors for end-stage renal failure. The value of microalbuminuria (urinary albumin excretion [UAE]: 30-300 mg/24 h) as an indicator of the glomerular filtration rate (GFR) is not known in these patients.
The relationships between microalbuminuria and GFR in subjects with NIDDM and hypertension were studied cross-sectionally (Study I) and longitudinally (Study II).
In study I, 205 NIDDM subjects with hypertension (151 with normoalbuminuria [UAE < 30 mg/24 h] and 54 with microalbuminuria) were studied. The GFR of subjects with normoalbuminuria (97 +/- 30 ml/min) (mean +/- SD), and microalbuminuria (97 +/- 27 ml/min; NS) were similar. Study II examined 51 of the subjects with normoalbuminuria and 21 with microalbuminuria 22 months (range 13-57) later. The GFR of subjects with microalbuminuria (-10 +/- 19 ml/min) declined more than in those with normoalbuminuria (+4 +/- 17 ml/min; Student's t-test: p = 0.0022). The predictive value of microalbuminuria for a drop in GFR was independent of the antihypertensive treatment used, the follow-up time, or changes in UAE. The only variable linked to GFR loss in subjects with microalbuminuria was an increase in diastolic blood pressure (p = 0.0298).
Microalbuminuria is a risk factor for a drop in GRF in NIDDM subjects with hypertension, and a reduction in blood pressure is the only effective way to prevent a loss of GFR in subjects with microalbuminuria.
高血压和非胰岛素依赖型糖尿病(NIDDM)是终末期肾衰竭的两个主要危险因素。在这些患者中,微量白蛋白尿(尿白蛋白排泄量[UAE]:30 - 300 mg/24 h)作为肾小球滤过率(GFR)指标的价值尚不清楚。
对NIDDM和高血压患者中微量白蛋白尿与GFR的关系进行了横断面研究(研究I)和纵向研究(研究II)。
在研究I中,对205例患有高血压的NIDDM患者进行了研究(151例为正常白蛋白尿[UAE < 30 mg/24 h],54例为微量白蛋白尿)。正常白蛋白尿患者的GFR(97 ± 30 ml/min)(均值 ± 标准差)和微量白蛋白尿患者的GFR(97 ± 27 ml/min;无显著性差异)相似。研究II在22个月(范围13 - 57个月)后对51例正常白蛋白尿患者和21例微量白蛋白尿患者进行了检查。微量白蛋白尿患者的GFR(-10 ± 19 ml/min)下降幅度大于正常白蛋白尿患者(+4 ± 17 ml/min;Student t检验:p = 0.0022)。微量白蛋白尿对GFR下降的预测价值与所用的抗高血压治疗、随访时间或UAE的变化无关。微量白蛋白尿患者中与GFR降低相关的唯一变量是舒张压升高(p = 0.0298)。
微量白蛋白尿是患有高血压的NIDDM患者GFR下降的危险因素,降低血压是预防微量白蛋白尿患者GFR丧失的唯一有效方法。